BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prozac
,
rs2230926
,
SIRT1
,
T cell receptor signaling pathway
,
Influenza
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
paromomycin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IFI6
EEF1E1
TBC1D9
CTSZ
RABGAP1L
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN
GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP
MORF_JAK3
Predicted Gene Targets for miR-496
CID domain
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
In Silico Selection and Validation of High-Affinity ssDNA Aptamers Targeting Paromomycin.
Production and statistical optimization of Paromomycin by Streptomyces rimosus NRRL 2455 in solid st…
Transmission potential of paromomycin-resistant Leishmania infantum and Leishmania donovani.
Paromomycin Sulfate Treatment in Histomoniasis Outbreaks in Three Commercial Turkey Flocks in the Fr…
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences betwe…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) …
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visc…
Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leish…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ